55
BigHat Biosciences raises $80M under Reg D 506(b) in San Mateo
Company raise · Raising · Offering $80M · Sold $75.1M · SAN MATEO, CA · filed 2026-10-26
35
BigHat Biosciences, Inc. files Form D
Company raise update · Closed · SAN MATEO, CA · Form D/A filed 2025-04-28
$50M+ raise
How this compares
- Among 1,633 fund launches filed from CA in the same window it is larger than 82%; the CA median is $19M.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Raise progress
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2025-04-28 | D/A | $124.1M | 40 | |
| 2026-10-26 | D | $75.1M | 29 | −$49M |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Bighat Biosciences on EDGAR
Earlier and related filings by the same issuer and sponsor.
People on the filing
| Francisco Gimenez | Director |
| Peyton Greenside | Executive Officer, Director |
| Steve Kafka | Director |
| Vineeta Agarwala | Director |
| Robert Chess | Director |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Peyton Greenside, Chief Executive Officer.
Why now — by persona
Relevant to: B2B software & services sales.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.